key: cord-1003338-scsgalx8
authors: Rouanet, J.; Lang, E.; Beltzung, F.; Evrard, B.; Henquell, C.; Joulie, I.; D’Incan, M.
title: Recent outbreak of chilblain‐like lesions is not directly related with SARS‐CoV‐2 infection
date: 2020-06-26
journal: J Eur Acad Dermatol Venereol
DOI: 10.1111/jdv.16776
sha: 0fc8068720a828fb0c1ba8aace647c05b06e8ad6
doc_id: 1003338
cord_uid: scsgalx8

Throughout March and April 2020, dermatologists have observed an outbreak of chilblains despite climatic conditions not conducive to their apparition. These lesions have occurred simultaneously to the COVID‐19 epidemic, suggesting a relationship between their onset and SARS‐CoV‐2 infection. Here we describe a series of 10 patients presenting chilblain‐like lesions in whom we have searched for evidence of SARS‐CoV‐2 infection.

Throughout March and April 2020, dermatologists have observed an outbreak of chilblains despite climatic conditions not conducive to their apparition. These lesions have occurred simultaneously to the COVID-19 epidemic, suggesting a relationship between their onset and SARS-CoV-2 infection.

Here we describe a series of 10 patients presenting chilblain-like lesions in whom we have searched for evidence of SARS-CoV-2 infection.

Between April 17 th and 29 th 2020, we have included patients successively referred to our Department for chilblain-like lesions. Present and past medical history were recorded along with complete skin exam. Blood samples were collected for blood cell count, CRP, liver and renal parameters, antinuclear antibodies (anti-ENA and anti-DNA antibodies if positive immunofluorescence), complement components, ANCA, cryoglobulins, anti-prothrombinase, anticardiolipids, coagulation factors and D-dimers. Serological status concerning human immunodeficiency virus, hepatitis viruses and SARS-CoV-2 were established using automated assays performed on an Abbott ARCHITECT i2000 (Abbott Diagnostics). Two biopsies were performed on lesional skin for diagnosis by light microscope examination and for SARS-CoV-2 search by RT-PCR test targeting the RNA-dependent RNA polymerase gene (https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detectionof-sars-cov-2-institut-pasteur-paris.pdf). We also searched for SARS-CoV-2 on a nasopharyngeal swab using RT-PCR.

Ten patients were included (median age: 33 years (11-57), sex-ratio 1:1). All had erythematous, 

This article is protected by copyright. All rights reserved patterns. SARS-CoV-2 research on nasopharyngeal swabs and on skin biopsies was negative and no SARS-CoV-2 specific IgG were detected in any case.

We present a series of 10 consecutive patients with typical clinical and pathological chilblains occurring during the peak of COVID-19 infection. In our area, the weather was warm at that time and all patients lived under lockdown in well-heated houses. In all patients, we failed to demonstrate neither a current nor recent COVID-19 infection nor SARS-CoV-2 presence in skin.

The absence of respiratory symptoms and the known rapid clearance of SARS-CoV-2 in moderate infections could explain the negativity of RT-PCR analysis. The absence of specific IgG suggests that a reaction due to COVID-19 is unlikely even though these patients could have only specific IgM. However, IgM peak between days 5 and 12 after infection [1] whereas IgG reach peak concentrations after day 20 and most patients were tested after 20 days of evolution of skin lesions. Furthermore, the sensitivity [2] of our test is 100% after day 17. Three of these patients had positive antinuclear antibodies suggesting an undiagnosed autoimmune disease (scleroderma or lupus) but no one presented other clinical symptoms.

Chilblain-like lesions have been reported for several weeks [3] [4] [5] 

Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in

Chilblains are a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

Chilblainlike lesions during COVID-19 epidemic: a preliminary study on 63 patients

The patients in this manuscript have given written informed consent to the

This article is protected by copyright. All rights reserved